Abstract
For some cancer survivors chemotherapy treatment is associated with lasting cognitive impairment, long after treatment cessation. Several candidate mechanisms have been suggested, yet clinical research has been unable to clearly tease apart these hypotheses. Rodent research has allowed a systematic study of these underlying mechanisms in the absence of potential patient confounds. Herein, this research is reviewed with emphasis on the role of the blood-brain barrier, neurogenesis, oxidative stress, white matter, immune system/(neuro) inflammation, HPA axis, blood flow, and cancer in chemotherapy-induced cognitive impairment. Furthermore, potential pharmacotherapy and behavioral intervention strategies are reviewed. This paper ends with methodological considerations in study of chemotherapy and cognition. (C) 2010 Elsevier Ltd. All rights reserved.
| Original language | English |
|---|---|
| Pages (from-to) | 729-741 |
| Number of pages | 13 |
| Journal | Neuroscience and Biobehavioral Reviews |
| Volume | 35 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Jan-2011 |
Keywords
- Animal model
- Chemotherapy
- Cytostatics
- Behavior
- Neurobiology
- Intervention strategies
- Learning
- Memory
- Cognition
- LONG-TERM-MEMORY
- HIPPOCAMPAL CELL-PROLIFERATION
- STANDARD-DOSE CHEMOTHERAPY
- INDUCED OXIDATIVE STRESS
- BREAST-CANCER PATIENTS
- RECEIVING ADJUVANT CHEMOTHERAPY
- CEREBELLAR GRANULE NEURONS
- SPATIAL WORKING-MEMORY
- WHITE-MATTER INTEGRITY
- CENTRAL-NERVOUS-SYSTEM